

JAMA Clinical Reviews
JAMA Network
Author interviews that explore the latest clinical reviews.
Episodes
Mentioned books
Jan 23, 2024 • 14min
USPSTF Recommendation: Screening for Speech and Language Delay and Disorders
Interview with Tumaini Rucker Coker, MD, MBA, USPSTF member and coauthor of Screening for Speech and Language Delay and Disorders in Children: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Screening for Speech and Language Problems in Young Children Recommendations for Speech and Language Screenings Screening for Speech and Language Delay and Disorders in Children Screening for Speech and Language Delay and Disorders in Children 5 Years or Younger
22 snips
Jan 16, 2024 • 13min
How Artificial Intelligence Has Evolved and the Implications for Health Care
Dr. Michael Howell discusses the evolution of AI in healthcare, from symbolic AI to AI 3.0. The limitations of AI 1.0 and the impact of biases in AI 2.0 are explored. Advancements in AI 3.0, such as foundation models and generative AI, are discussed. The importance of clinicians understanding different AI models and gaining first-hand experience is emphasized.
5 snips
Jan 9, 2024 • 14min
Age-Related Macular Degeneration
Age-related macular degeneration affects approximately 196 million people worldwide and is a leading cause of visual impairment. In this JAMA podcast, JAMA Deputy Editor Mary McGrae McDermott, MD, interviews author Usha Chakravarthy, MD, PhD, Queen's University of Belfast, Northern Ireland, about the causes, diagnosis, and treatment of age-related macular degeneration. Related Content: Age-Related Macular Degeneration
Jan 2, 2024 • 24min
JAMA Editors' Choice 2023: Clinical Reviews Podcasts
JAMA editors highlight top 2023 Clinical Reviews podcasts, including cirrhosis management, heart failure treatments, worsening US maternal death rates, and addressing obstetric racism.
Dec 26, 2023 • 18min
Postpartum Depression
Perinatal mental health conditions are a leading cause of overall and preventable maternal mortality. JAMA Deputy Editor Linda Brubaker, MD, MS, discusses postpartum depression with author Tiffany A. Moore Simas, MD, MPH, MEd, chair of the Department of Obstetrics and Gynecology at the University of Massachusetts. Related Content: A Fast-Acting Pill Received Approval for Postpartum Depression—Is It a Game Changer? Postpartum Depression—New Screening Recommendations and Treatments
Dec 19, 2023 • 18min
Diagnosis and Treatment of Morton Neuroma, Plantar Fasciitis, and Achilles Tendinopathy
Discover the diagnosis and treatment of Morton neuroma, plantar fasciitis, and Achilles tendinopathy. Learn about diagnostic tests for Morton's neuroma, the use of eccentric exercises for Achilles tendonitis, and the risk factors associated with Achilles tendonitis. Explore novel treatments like platelet-rich plasma and extra-corporeal shockwave therapy for foot disorders.
Dec 12, 2023 • 11min
Metformin for Diabetes in Pregnancy
Dr. Denice Feig, professor of medicine at the University of Toronto, talks about using metformin for diabetes in pregnancy, discussing new trials and benefits such as improved glycemic control and reduced maternal weight gain. The podcast also highlights the need for more research on long-term effects of metformin on obesity and diabetes risk in children.
Dec 5, 2023 • 15min
Improving Cardiovascular Health During the Postpartum Period
Deaths during pregnancy and in the early postpartum period have increased in the US over the past several years, and approximately 80% of these deaths are considered preventable. JAMA Senior Editor Kristin L. Walter, MD, MS, speaks with Sadiya S. Khan, MD, MSc, from Northwestern University about the importance of monitoring and improving cardiovascular health during the postpartum period. Related Content: Cardiovascular Health in the Postpartum Period
Nov 28, 2023 • 18min
Obesity Management in Primary Care
Obesity affects approximately 42% of adults in the US. Multiple strategies are available to treat obesity, including behavior therapies, GLP-1 receptor agonists, and bariatric surgery. Therapies vary in effectiveness and risks. JAMA Deputy Editor Mary McGrae McDermott, MD, discusses evidence-based obesity treatment with Melanie Jay, MD, MS, New York University Grossman School of Medicine. Related Content: Obesity Management in Adults As Semaglutide's Popularity Soars, Rare but Serious Adverse Effects Are Emerging FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management
Nov 21, 2023 • 19min
High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury
Critical bleeding is associated with a high mortality rate in patients with trauma. JAMA Associate Editor Christopher W. Seymour, MD, MSc, discuses the results of the CRYOSTAT-2 trial with Nicola Curry, MD, Oxford University Hospitals, and Ross Davenport, PhD, Centre for Trauma Sciences, UK. Related Content: Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury


